Orchid Pharma Limited (ORCHPHARMA) — Announcement | 11 June 2026

StockFin.ai

Try Free

📢 Key Event
GST department issues demand order for Rs. 1.67 crores plus interest

💡 Investor Takeaway
Investors should note the company views the liability as resolved through the acquisition process and expects no material financial impact.

Orchid Pharma disclosed a GST department order demanding Rs. 1.67 crores plus interest for a pre-acquisition period, but stated the liability is addressed under an approved insolvency resolution plan and will not materially affect financials or operations. The company plans to appeal the order while emphasizing legal remedies.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ORCHPHARMA ✨ Ask AI About This

About Orchid Pharma Limited (ORCHPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹3,614.24 Cr P/E: 32.3

View full ORCHPHARMA stock details →

📡 Get AI alerts when ORCHPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ORCHPHARMA — Free

💡 Ask AI about this filing

"How does this affect ORCHPHARMA margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More ORCHPHARMA filings

See all ORCHPHARMA filings →

🔥 Also filed on 11 June 2026

SUNPHARMA Sun Pharmaceutical Industries Limited Corporate Action INDOTECH Indo Tech Transformers Limited Financial Results PATELRMART Patel Retail Limited Financial Results AGSTRA AGS Transact Technologies Limited Financial Results ASTRAL Astral Limited Announcement AVANTIFEED Avanti Feeds Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ORCHPHARMA files new disclosures

Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ORCHPHARMA — Free

Free account · 2 AI queries/day